The purpose of this study is to assess conclusive efficacy of stem cells for the treatment of cerebral palsy in 45 subjects over 11 months.
http://world.einnews.com/pr_news/136248201/rnl-bio-filed-phase-ii-iii-clinical-trial-with-kfda-to-treat-cerebral-palsy-using-autologous-fat-derived-stem-cells
http://world.einnews.com/pr_news/136248201/rnl-bio-filed-phase-ii-iii-clinical-trial-with-kfda-to-treat-cerebral-palsy-using-autologous-fat-derived-stem-cells
No comments:
Post a Comment